Skip to content

Suprima II Model 254-26

by Intermedics, Inc. 510(k)

Active United States

510(k) K852431

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK852431 Date19 Jul 1985ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DXY
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Suprema II Model 254-26 is an implantable pacemaker pulse-generator, designed to regulate cardiac rhythm by delivering electrical impulses to the heart. This device is classified as a Class III medical device under FDA regulations, intended for patients requiring artificial cardiac pacing to manage bradycardia or other conduction disorders.

This pulse-generator is supplied sterile and intended for single-use implantation by qualified healthcare professionals in a clinical setting. It is regulated under FDA 510(k) clearance (K852431) and adheres to the specifications outlined in regulation number 870.3610. The device is not MRI-safe and must be handled with care to ensure proper functionality and patient safety.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical condition is this device intended to address, and how does it work?

    The Suprema II Model 254-26 is designed to address bradycardia or conduction disorders by regulating cardiac rhythm. It functions as an implantable pacemaker pulse-generator, delivering controlled electrical impulses to the heart to maintain a proper heartbeat when the natural conduction system fails.

  • Is this device intended for reuse, or is it meant to be implanted as a single-use device?

    This device is explicitly intended for single-use implantation. It is supplied sterile and must be implanted by qualified healthcare professionals in a clinical setting, ensuring patient safety and proper functionality.

  • What regulatory pathway was followed for this device’s clearance, and which committee reviewed it?

    The Suprema II Model 254-26 followed the FDA’s 510(k) clearance pathway, specifically under the traditional review process. It was classified as substantially equivalent (SESE) and reviewed by the Cardiovascular (CV) Advisory Committee.

  • Can this device be used in patients who require MRI procedures, or are there specific safety concerns?

    This device is explicitly not MRI-safe. It must be handled with care, and MRI procedures should be avoided to prevent interference with its functionality or potential harm to the patient.

  • How is the device supplied, and what precautions should be taken during handling?

    The device is supplied sterile and intended for direct implantation by trained professionals. Since it is single-use, proper sterile techniques must be followed during handling to prevent contamination and ensure safe implantation.